Company / Operating Income per Share
CRESCENT BIOPHARMA, INC. Operating Income per Share History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$149.84
FY2025
5-year range
-$149.84 / $2.55
FY2021-FY2025
Trend
-27150.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income per Share changed -27150% YoY in FY2025, a notable deviation from the 4-year average annual change of -6818%.
Based on SEC 10-K filings.
-149.84 in FY2025.
Declined from $-0.58 to $-149.84 over the past 9 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income per share decreased 27150.1% year-over-year.
- Peak operating income per share was recorded in FY2014.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.35 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$149.84 | -27150.1% |
| FY2017 | -$0.55 | +6.0% |
| FY2016 | -$0.58 | -4.4% |
| FY2015 | -$0.56 | -122.0% |
| FY2014 | $2.55 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026